“…SIRT1 inactivates p53 and subsequently inhibits p53-mediated apoptosis induced by ROS through deacetylation of p53 [Luo et al, 2001;Vaziri et al, 2001]. Because ROS are well known as major contributors to NIHL [Henderson et al, 2006;Yuan et al, 2015], SIRT1 should be considered a potential target for treatment of NIHL and protection of cochlear hair cells. Moreover, our previous studies demonstrated that SIRT1 is abundantly expressed in the cochlea and downregulated with aging, which is correlated with activation of cochlear p53, cochlear hair cell loss, and age-related hearing loss [Xiong et al, 2014[Xiong et al, , 2015.…”